An Antimicrobial Blue Light Prototype Device Controls Infected Wounds in a Preclinical Porcine Model - Takeaways - MDSpire

An Antimicrobial Blue Light Prototype Device Controls Infected Wounds in a Preclinical Porcine Model

  • By

  • Laisa Bonafim Negri

  • William Farinelli

  • Sandeep Korupolu

  • Ying Wang

  • Yara Mannaa

  • Hang Lee

  • Jie Hui

  • Pu-Ting Dong

  • Andrea Slate

  • Joshua Tam

  • R Rox Anderson

  • Seok-Hyun Andy Yun

  • Jeffrey A Gelfand

  • November 13, 2024

  • 0 min

Share

  • 1

    A prototype antimicrobial blue light (ABL) device significantly reduced MRSA infection in swine wounds by over 99.99% after just two treatments.

  • 2

    The ABL device utilizes 405 nm light to produce reactive oxygen species, effectively killing bacteria in both planktonic and biofilm states.

  • 3

    This device aims to complement antibiotic therapy, potentially reducing antibiotic use and the risk of developing antimicrobial resistance.

  • 4

    The study highlights the porcine model's relevance for testing wound treatments before human trials, particularly for MRSA infections.

  • 5

    No FDA or EU registered devices currently exist for treating significant cutaneous wound infections with ABL, indicating a need for further development.

Original Source(s)

An Antimicrobial Blue Light Prototype Device Controls Infected Wounds in a Preclinical Porcine Model

  • by Laisa Bonafim Negri, William Farinelli, Sandeep Korupolu, Ying Wang, Yara Mannaa, Hang Lee, Jie Hui, Pu-Ting Dong, Andrea Slate, Joshua Tam, R Rox Anderson, Seok-Hyun Andy Yun, Jeffrey A Gelfand

  • November 13, 2024

Related Content

Case Report: Moxibustion-induced burns leading to disseminated methicillin-resistant Staphylococcus aureus infection in a patient with type 2 diabetes mellitus

Bone and Joint Infections in Tropical Settings: High Prevalence of Gram-Negative Bacilli and Implications for Empirical Therapy

Geospatial and Temporal Assessment of Tuberculosis Incidence in Iran